SCHEDULE 13D

Company

Intellia Therapeutics, Inc.

Filed

May 20, 2016

Accession Number

0000947871-16-001203

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →